President Trump unveiling the framework for a trade deal with the UK, his first since the ‘reciprocal’ tariff pause. How those details will impact broader markets. Plus, the latest move in Alphabet after yesterday’s search drama, and what a “most favored nation” policy means for drug pricing and stocks. One top health care analyst weighs in. 

Fast Money Disclaimer

Apple and Alphabet dip after one top exec weighs in on the AI/search engine revolution. What one tech analyst sees in store for the industry, and if there’s any reason to be bullish on the group. Plus, China stocks slide despite stimulus and a rate cut, as President Trump holds steady on tariffs. And the whole new world for Disney  as the media giant plans to put magic in the middle east.

Fast Money Disclaimer

Another key Fed decision on deck, as the recent stock market bounce loses steam. What to expect from Fed Chair Jerome Powell, and what it will mean for the market’s next move. Plus Earnings season in full swing, and Wegovy-maker Novo Nordisk is ready to report. Why one top healthcare analyst is eyeing potential tariff risks and political overhang as a headwind for the whole weight loss drug space.

Fast Money Disclaimer

Oil prices drop to 4-year lows as OPEC+ agrees to hike output. Why one top energy analyst sees crude crumbling to $40 per barrel before pumping higher. Plus Ford reports earnings, Skechers laces up to go private, and Trump takes aim at movie studios with new tariff threats. How Needham’s Senior Internet and Media Analyst Laura Martin sees it impacting the streaming landscape.

Fast Money Disclaimer

Major markets rallied on Friday after a stronger-than-expected jobs report and news that Beijing might be paving the way for trade talks. Can the momentum continue? Plus investors descending on Berkshire Hathaway’s annual meeting this weekend. And the legendary value investor may be seeing a signal that markets are cheap right now.

Fast Money Disclaimer

Earnings season is in full swing, with Apple and Amazon headlining the action. Deepwater Asset Management’s Gene Munster joins to break down the key takeaways from the day’s big reports. And Eli Lilly dropping as the drugmaker cuts its profit forecast. Mizuho’s Jared Holz digs into the details, and where the pharma space is heading next. Plus, how the markets are setting up ahead of tomorrow’s jobs report. 

Fast Money Disclaimer

A slew of earnings roll in with Meta and Microsoft among the names reporting. Deepwater Asset Management Gene Munster joins to dig into where he sees tech heading next. Plus, markets tumble after a surprise GDP result, Telsey Advisory Group CEO Dana Telsey on the retail impact of tariffs, and how Starbucks is faring after their disappointing results.

Fast Money Disclaimer

President Trump notching his second First 100 days in office, and with stocks seeing their worst start to a term since Richard Nixon, will there be even more downside ahead, or can the climb back continue? And pumping the brakes on auto tariffs. How the White House is stopping a “stacked” tax, and what it means for the automakers scrambling to get ahead of the tariffs.

Fast Money Disclaimer

Big tech earnings are coming up and top tech analyst Dan Niles says the bar has been raised for the group. Where he sees the space heading next. Plus, Why transport stocks are flashing warning signs, prices hikes from China retailers, a bearish call on pharma, and why foreign investors could pull out of U.S. assets.

Fast Money Disclaimer

Stocks closing out a positive week, as tech stocks lead the market bounce with a big move off its recent lows. How our traders are positioning ahead of another big week of earnings, headlined by Apple, Microsoft, and Meta. Plus A major pharma fee. The $51 billion Trump’s tariffs could add to U.S. drug costs, and where one industry expert is still seeing opportunity in the space.

Fast Money Disclaimer